| Pilot Grants Awarded
I am pleased to announce the recipients of this year's Pilot Grant Awards Program. We received more than 45 outstanding applications for funding and were able to support 10 projects, all wonderful examples of integrated translational research here at Yale Cancer Center.
Congratulations to the following recipients:
Jeffrey L. Sklar, MD, PhD, Joachim Baehring, MD, and Anita Hunter, MD, PhD Development and Application of a Novel Diagnostic Method for in Situ Assessment of Tissue Clonality
Tae Hoon Kim, PhD, David Tuck, MD, and Lyndsay Harris, MD Epigenetic Modulation of Breast Cancer Amplicons
Akiko Iwasaki, PhD and Daniel DiMaio, MD, PhD Suppression of Dendritic Cells by HPV+ Cervical Cancer
Elias Lolis, PhD and Edward Chu, MD Structural Basis for Translational Auto-regulation of Thymidylate Synthase and Dihydrofolate Reductase
Abhijit Patel, MD, PhD and Roy Decker, MD, PhD Tumor-derived Circulating Mutant K-ras DNA as a Biomarker for Radiation Response: A Novel Deep Sequencing Approach
Frank J. Slack, PhD Mouse Transgenic microRNA Models of Cancer
Ruslan Medzhitov, PhD Role of Macrophages in Intestinal Tumorigenesis
Joshua N. VanHouten, PhD PMCA2, Apoptosis and Skeletal Metastatic Disease in Breast Cancer
Yong Zhu, PhD Wm. Kevin Kelly, DO Fusion Genes, Circadian Genes and High Grade Prostate Cancer
Cary P. Gross, MD A Novel Approach to Assessing the Health Status of Older Patients with Colon Cancer
Faculty Conclave
All cancer center faculty members are invited to the Yale Cancer Center Faculty Conclave, a new event that I plan to schedule annually.
Please save the date for the evening of Monday, November 23rd. Details will follow.
Grand Rounds
Please join us for our first Grand Rounds presentation of the academic year on Tuesday, September 15th at noon in Brady Auditorium. We are launching a new format for the Rounds, featuring two 20-minute presentations. Attendance at Grand Rounds is an important component of Yale Cancer Center membership.
Learn More >>
|
Smilow Update
The construction team at Smilow Cancer Hospital is working on the finishing details of the entrance and lobby for the building opening in October. Final set-up is in progress on the 4 MRIs that are installed in the building. The Radiation Oncology (LL), the Breast Center (1), and Gynecologic Oncoloy (1) clinic spaces are nearly complete. On the second floor, the diagnostic radiology space is in the final stages of construction. All elevators are scheduled for installation within the next two weeks.
|
Shared Resource Highlight
Immune Monitoring
The Immune Monitoring Core Facility provides a core resource for clinical and translational research protocols that involve immunotherapy and/or that affect the human immune system. Consultations regarding optimal immunologic assessment, assay development for innovative evaluation approaches, and provision of assays on a fee-for-service basis are all part of our mission.
For more information on the services of the Immune Monitoring Shared Resource or to request a service, please visit their website.
Learn More >>
Dr. Brian Smith, Director
(203) 688-2286
Dr. Lesley Devine, Science Director
(203) 785-2031
|
Recent Publications
Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer.
Nadler Y, González AM, Camp RL, Rimm DL, Kluger HM, Kluger Y.
Ann Oncol. 2009 Aug 28.
Read More >>
Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer.
Saif MW.
World J Gastroenterol. 2009 Aug 21;15(31):3855-64.
Read More >>
Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements.
Szpakowski S, Sun X, Lage JM, Dyer A, Rubinstein J, Kowalski D, Sasaki C, Costa J, Lizardi PM.
Gene. 2009 Aug 20.
Read More >>
The Utility of Screening in the Design of Trials for Symptom Management in Cancer.
Jeon S, Given CW, Sikorskii A, Given B.
J Pain Symptom Manage. 2009 Aug 19.
Read More >>
Rash associated with the use of pegylated filgrastim in a patient with advanced pancreatic cancer.
Bustillo I, Kaley K, Saif MW.
Cutan Ocul Toxicol. 2009 Aug 20.
Read More >>
|
| |
|
Inside Yale Cancer Center
7-Digit Dialing at YNHH
YNHH has moved from 5-digit phone dialing for internal calls to use of 7-digit dialing.
Learn More >>
CR Article
What happens to a donated tumor?
Hope, Not Fear
Share the invite to our annual breast cancer symposium with your patients.
|
Events
September 6; 6:00 PM Yale Cancer Center Answers
Cancer Genetic Counseling
Ellen Matloff, MS
WNPR 90.5 FM
Learn More >>
September 13; 9:30 AM
Discovery to Cure Walk
To Benefit Ovarian Cancer Research
Sherwood Island State Park
September 15; 12:00 PM
Yale Cancer Center Grand Rounds
Brady Auditorium
Targeted Therapy for Lung Cancer
Dr. Thomas Lynch
Functional and Genomic Analysis of the Melanoma Kinome
Dr. David Stern
Learn More >>
|
Submissions
Please submit your recent publication and grant announcements to:
Renee Gaudette
Director, Public Affairs and Marketing
renee.gaudette@yale.edu
|
|
|
